Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · IEX Real-Time Price · USD
2.510
+0.030 (1.21%)
At close: May 31, 2024, 4:00 PM
2.450
-0.060 (-2.39%)
After-hours: May 31, 2024, 4:07 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $175.19 million as of May 31, 2024. Its market cap has decreased by -34.14% in one year.
Market Cap
175.19M
Enterprise Value
106.68M
1-Year Change
-34.14%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since January 15, 2021, Alpha Tau Medical's market cap has decreased from $256.50M to $175.19M, a decrease of -31.70%. That is a compound annual growth rate of -10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2024 | 174.90M | 0.40% |
| May 30, 2024 | 174.20M | 1.22% |
| May 29, 2024 | 172.10M | - |
| May 28, 2024 | 172.10M | -2.38% |
| May 24, 2024 | 176.30M | -4.50% |
| May 23, 2024 | 184.60M | -2.22% |
| May 22, 2024 | 188.80M | - |
| May 21, 2024 | 188.80M | - |
| May 20, 2024 | 188.80M | -4.26% |
| May 17, 2024 | 197.20M | 6.02% |
| May 16, 2024 | 186.00M | 0.76% |
| May 15, 2024 | 184.60M | 0.60% |
| May 14, 2024 | 183.50M | -0.60% |
| May 13, 2024 | 184.60M | 2.33% |
| May 10, 2024 | 180.40M | 4.82% |
| May 9, 2024 | 172.10M | 2.50% |
| May 8, 2024 | 167.90M | -1.64% |
| May 7, 2024 | 170.70M | -0.41% |
| May 6, 2024 | 171.40M | -1.21% |
| May 3, 2024 | 173.50M | 5.99% |
| May 2, 2024 | 163.70M | -3.31% |
| May 1, 2024 | 169.30M | -2.81% |
| Apr 30, 2024 | 174.20M | 4.19% |
| Apr 29, 2024 | 167.20M | -0.24% |
| Apr 26, 2024 | 167.60M | 0.24% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 179.14M |
| Lifecore Biomedical | 178.39M |
| OrganiGram Holdings | 176.76M |
| Acumen Pharmaceuticals | 176.63M |
| Accuray | 175.66M |
| bluebird bio | 174.12M |
| G1 Therapeutics | 172.53M |
| Rigel Pharmaceuticals | 171.51M |